Repeated Treatment with Levoprotiline, a Novel Antidepressant, Up-Regulates Histamine H1 Receptors and Phosphoinositide Hydrolysis Response In Vivo.
スポンサーリンク
概要
- 論文の詳細を見る
The effects of repeated administration of levoprotiline, a novel type of tetracyclic antide-pressant on histamine H<SUB>1</SUB>, muscarinic acetylcholine and α<SUB>1</SUB>-adrenergic receptors and the response of phosphoinositide hydrolysis (PI) stimulated by histamine in the cortex of the rat brain were investigated. Histamine H<SUB>1</SUB> receptors were up-regulated to 120% and PI response stimulated by histamine was enhanced to 160%-200% after repeated treatment with levoprotiline (20 mg/kg, i.p., once a day for 28 days) when compared to that of the saline-treated group. No significant alterations of muscarinic acetylcholine and α<SUB>1</SUB>-adrenergic receptors were observed. This demonstrates that the repeated treatment with levoprotiline has prominent action on the regulation of histamine H<SUB>1</SUB> receptors and PI response coupling to histamine H<SUB>1</SUB> receptors in vivo.
- 公益社団法人 日本薬理学会の論文
著者
-
Inukai Toshiya
Biological Research Laboratories, Pre-Clinical Research Department, Research & Development Sub-division, Pharmaceutical Division, Ciba-Geigy (Japan) Limited
-
Noguchi Seiji
Biological Research Laboratories, Pre-Clinical Research Department, Research & Development Sub-division, Pharmaceutical Division, Ciba-Geigy (Japan) Limited
関連論文
- Repeated Treatment with Levoprotiline, a Novel Antidepressant, Up-Regulates Histamine H1 Receptors and Phosphoinositide Hydrolysis Response In Vivo.
- Antagonism of picrotoxin against the taming effect of carbamazepine on footshock induced fighting behavior in mice.